FY2025 Earnings Estimate for CVE:HIV Issued By Roth Capital

HIVE Blockchain Technologies Ltd. (CVE:HIV) – Equities researchers at Roth Capital upped their FY2025 earnings per share (EPS) estimates for HIVE Blockchain Technologies in a research note issued to investors on Wednesday, January 8th. Roth Capital analyst D. Aftahi now anticipates that the company will post earnings of ($0.53) per share for the year, up from their previous forecast of ($0.54). Roth Capital has a “Strong-Buy” rating on the stock. Roth Capital also issued estimates for HIVE Blockchain Technologies’ Q4 2025 earnings at ($0.10) EPS, Q1 2026 earnings at ($0.09) EPS, Q3 2026 earnings at ($0.09) EPS, FY2026 earnings at ($0.16) EPS and FY2028 earnings at ($0.09) EPS.

A number of other research analysts have also recently commented on the company. Keefe, Bruyette & Woods raised HIVE Blockchain Technologies to a “moderate buy” rating in a research note on Wednesday, January 8th. Northland Capmk raised HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Thursday, September 19th. Finally, Cantor Fitzgerald raised HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Tuesday, October 29th. Four research analysts have rated the stock with a strong buy rating, According to data from MarketBeat, the company has an average rating of “Strong Buy”.

HIVE Blockchain Technologies Stock Performance

HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.